biopharmaceuticalprojectplanning.blogspot.com
Biopharmaceutical Project Planning: Successful Biopharmaceutical Project Planning: How to get it right from the beginning
http://biopharmaceuticalprojectplanning.blogspot.com/2005/11/successful-biopharmaceutical-project.html
Monday, November 21, 2005. Successful Biopharmaceutical Project Planning: How to get it right from the beginning. By Subhadra Modukuri MS. What work needs to be done;. How it will be done (according to which standards, specifications, best practices);. Who should do the work (and where);. How long the work will take;. How much it will cost, both to "resource" the infrastructure and to do the content conversion;. Where, after having answered all of these questions, one might obtain funding. It can be conc...
futureoutsourcingclinicalresearch.blogspot.com
Future of Outsourcing Clinical Research: The Future Outlook of Outsourcing Clinical Research
http://futureoutsourcingclinicalresearch.blogspot.com/2005/11/future-outlook-of-outsourcing-clinical.html
Future of Outsourcing Clinical Research. Monday, November 21, 2005. The Future Outlook of Outsourcing Clinical Research. As presented by Dr. Jayashree, Officer Clinical Services, SPIC Pharma. Outsourcing offers a number of advantages to the companies. These include:. Reduces the time (8 to 15 years) required to develop and bring a new drug to market;. Non-availability of services in-house;. Less knowledge of regulatory affairs in a particular country of interest;. Increased complexity of clinical trials;.
futureoutsourcingclinicalresearch.blogspot.com
Future of Outsourcing Clinical Research: November 2005
http://futureoutsourcingclinicalresearch.blogspot.com/2005_11_01_archive.html
Future of Outsourcing Clinical Research. Monday, November 21, 2005. The Future Outlook of Outsourcing Clinical Research. As presented by Dr. Jayashree, Officer Clinical Services, SPIC Pharma. Outsourcing offers a number of advantages to the companies. These include:. Reduces the time (8 to 15 years) required to develop and bring a new drug to market;. Non-availability of services in-house;. Less knowledge of regulatory affairs in a particular country of interest;. Increased complexity of clinical trials;.
alzheimersdiseasehistaminetherapy.blogspot.com
Alzheimer’s Disease Histamine Therapy Research: Novel Histamine Therapy Undergoing Clinical Trials
http://alzheimersdiseasehistaminetherapy.blogspot.com/2005/11/novel-histamine-therapy-undergoing.html
Alzheimer’s Disease Histamine Therapy Research. Monday, November 28, 2005. Novel Histamine Therapy Undergoing Clinical Trials. By O’Rita M. Siddall. Histamine and the Brain. Histaminergic cell bodies are located exclusively in the tuberomammillary nucleus of the hypothalamus, and project to all major areas of the brain involved in the regulation of many brain functions, like the sleep/wake cycle and memory processing [5]. Histamine and Brain Disease. Novel Histamine (H3) Receptor Antagonist Therapy.
fdafinancialdisclosurerules.blogspot.com
FDA Financial Disclosure Rules: November 2005
http://fdafinancialdisclosurerules.blogspot.com/2005_11_01_archive.html
FDA Financial Disclosure Rules. Tuesday, November 22, 2005. Financial Disclosure Required by Clinical Investigators. As written by Shilpa Sadekar. Drug companies submitting licensing applications to the Food and Drug Administration (FDA) in the United States will now have to reveal whether researchers involved in a drug trial have any financial interest in the company. The new regulations aim to eliminate possible data bias arising from financial considerations [3]. Under the applicable regulations (21 C...
fdafinancialdisclosurerules.blogspot.com
FDA Financial Disclosure Rules: Financial Disclosure Required by Clinical Investigators
http://fdafinancialdisclosurerules.blogspot.com/2005/11/financial-disclosure-required-by.html
FDA Financial Disclosure Rules. Tuesday, November 22, 2005. Financial Disclosure Required by Clinical Investigators. As written by Shilpa Sadekar. Drug companies submitting licensing applications to the Food and Drug Administration (FDA) in the United States will now have to reveal whether researchers involved in a drug trial have any financial interest in the company. The new regulations aim to eliminate possible data bias arising from financial considerations [3]. Under the applicable regulations (21 C...
clinicaltrialstudyprotocol.blogspot.com
Clinical Trial Study Protocol: Study Protocol Considerations in Recruiting Patients for Clinical Trials
http://clinicaltrialstudyprotocol.blogspot.com/2005/11/study-protocol-considerations-in.html
Clinical Trial Study Protocol. Monday, November 14, 2005. Study Protocol Considerations in Recruiting Patients for Clinical Trials. A clinical trial starts with developing a study protocol that is feasible without being too restrictive in its inclusion/exclusion criteria. Study designs that are conceptually simple, and that address questions of clinical relevance where genuine uncertainty exists, are likely to facilitate the recruitment of participants. ClinQua CRO ( www.clinqua.com. It is important to n...
